Amylyx Pharmaceuticals, Inc.
NASDAQAMLX cost to borrow surges to 7.77%, up 1,301% in one week as short-squeeze momentum accelerates post-earnings rally.
Snapshot as of 18 Sept 2026
AMLX just delivered one of the sharpest single-session moves in small-cap biotech this year, and the Street is still scrambling to reprice it. The stock closed at $35.11 on Tuesday, up 64% on the day and nearly 49% on…
Amylyx Pharmaceuticals heads into its August 6 earnings report with the most prominent recent signal coming from the analyst community, not the short-selling camp. Citigroup raised its price target on AMLX to $26 from…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AMLX — free to start on ORTEX.
Sign up for free →Open AMLX on ORTEX